Oncoinvent

Oslo, Norway

Oncoinvent develops new radiopharmaceutical products for better treatment options for cancer patients.

$11.8M raised

Dec 2024

Undisclosed

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Oncoinvent raised?

Oncoinvent has raised $11.8M in total funding. The most recent round was Undisclosed. The last funding was announced in December 2024.

Who are Oncoinvent's investors?

Oncoinvent's investors include Hadean Ventures, Canica, MP Pensjon, Watrium AS, Geveran Trading.

Where is Oncoinvent headquartered?

Oncoinvent is headquartered in Oslo, Norway.

What does Oncoinvent do?

Oncoinvent develops new radiopharmaceutical products for better treatment options for cancer patients.

What stage is Oncoinvent at?

Oncoinvent is at the Undisclosed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 4, 2024.

MLA

"Oncoinvent — Funding & Investors." VCBacked, December 4, 2024, https://www.vcbacked.co/company/oncoinvent. Accessed July 2, 2026.

APA

VCBacked. (2024). Oncoinvent — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/oncoinvent

Wikipedia (cite web)

{{cite web |title=Oncoinvent — Funding & Investors |url=https://www.vcbacked.co/company/oncoinvent |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 4, 2024.